The numbers surged. The graph spiked. But the soul remained quiet.
It started with a whisper from Crypto Briefing—an outlet better known for tracking token flips than medical breakthroughs. The rumor: OpenEvidence, an AI platform claiming 40% of U.S. doctors as users, was raising $200 million at a $20 billion valuation. My first instinct was not awe. It was a familiar knot in my stomach—the same one I felt watching Terra’s algorithmic stability unravel in 2022, or when Uniswap’s liquidity mining programs promised users a yield that evaporated the moment incentives stopped.
This is the story of a valuation built on air, of a centralized data silo wearing the crown of innovation, and of the quiet lessons Web3 builders must carry forward.
Context: The Centralized Data Castle
OpenEvidence, if the reports are accurate, is a medical AI assistant. It promises to shorten the time doctors spend sifting through journals, drug databases, and patient histories. That’s a noble goal. As someone who spent years auditing smart contracts for Gitcoin Grants—where we used quadratic voting to fund public goods—I understand the power of information access. But the foundation of this empire is a black box. No technical architecture. No revenue figures. No FDA clearance status. Just a number: $20 billion.
In 2017, I left corporate cybersecurity to join Gitcoin. While others chased ICO tokens, I manually audited the quadratic voting prototypes, convinced that code could enforce fairness. That idealism still burns, but it’s tempered by experience. In 2021, consulting for an NFT marketplace, I discovered a royalty enforcement mechanism that would penalize secondary creators. I spent two weeks drafting alternatives, standing alone against leadership. I learned that transparency is not just a feature—it’s a prerequisite for trust. OpenEvidence offers neither.
Core: The Hidden Cost of Centralized Medical AI
Data Silos and the Liquidity Mining Parallel
At its core, OpenEvidence is a data aggregator. It ingests medical literature, clinical notes, and drug information, then applies a large language model to answer doctors’ questions. That sounds like a classic AI win. But look closer. The data comes from hospitals, publishers, and electronic health records—each a silo. The model is trained on proprietary datasets, locked behind APIs. The doctors who contribute their queries and corrections? They are the unpaid labor fueling the flywheel, much like liquidity providers in DeFi summer who farmed tokens without any governance power.
I saw this play out in 2020. I was a Senior PM for a DeFi liquidity protocol. We were pressured to launch yield farming programs that rewarded speculation over utility. I refused. I fought three months in boardrooms dominated by men who called my concerns “soft.” Eventually, I won, but the scars remain. The lesson: short-term TVL spikes are not sustainable. OpenEvidence’s 40% user adoption might be real, but without transparent metrics—retention, active usage, paying customers—it’s just another TVL number.
The Regulatory Time Bomb
Medical AI operates under a different gravity. The FDA classifies software that influences clinical decisions as a medical device. One wrong diagnosis from a hallucinated model and lives are at stake. In 2025, I served as a technical advisor for a coalition lobbying for Bitcoin ETF regulations. I translated cryptographic proofs into policy briefs. I learned that regulators move slowly, but when they move, they crush. OpenEvidence’s valuation assumes they’ve cleared all hurdles. But they haven’t published any FDA status. They haven’t shared a third-party audit of their model’s accuracy. This is not a stablecoin peg; it’s a ticking bomb.
The Terra/Luna Reflection
After the Terra collapse, I retreated. I spent months questioning whether our entire industry was built on flawed premises. I held small, private discussions with fellow developers, focusing on rebuilding through transparency. OpenEvidence’s valuation feels like a ghost of that era. A $20 billion rumor based on unverified usage data is algorithmic stability in disguise—numbers that look real until the market asks for proof.
A Decentralized Alternative: ZK-Powered Medical Data
What if doctors could query a model trained on encrypted patient data, using zero-knowledge proofs to verify accuracy without exposing privacy? What if the dataset itself was owned by a DAO of patients and researchers, funded through quadratic voting? This is not fantasy. I’ve seen Gitcoin’s quadratic funding allocate millions to open-source projects. I’ve seen the potential for sustainable ecosystems that prioritize longevity over extraction.
Blockchain can offer auditability, consent, and ownership. Imagine a medical AI where every inference is recorded on a public ledger, where patients can grant or revoke data access in real-time, and where the model’s performance is transparent to all. That is true infrastructure. OpenEvidence is a walled garden. We need an open field.
Contrarian: The Pragmatic Trap
Some argue that centralization is necessary for medical AI—that regulation requires a single accountable entity, and that decentralized governance is too slow for life-or-death decisions. I’ve heard this same argument about blockchain scaling: “ZK proofs are too slow.” In 2025, ZK rollups are processing millions of transactions daily. The technology matures. The regulatory bridge is built. The same can happen for medical data. The real risk is not decentralization—it’s a single point of failure. OpenEvidence’s $20 billion valuation is a vulnerability. One data breach, one FDA rejection, one lawsuit, and the castle falls.
Takeaway: When the Graph Spikes, Listen to the Soul
I’ve been in this industry long enough to see cycles repeat. The ICO boom. DeFi summer. NFT mania. Each time, the chart spikes, and the soul—the original vision of equitable, transparent infrastructure—grows quieter. OpenEvidence is a symptom of a deeper disease: the belief that valuation equates to value.
The next wave of medical AI won’t be built on siloed datasets and $20 billion rumors. It will be built on open protocols, user-owned data, and cryptographic proofs. When the graph spikes again, I’ll be listening for the soul.
